CoChat

A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression”

Open access
Taragano, F.E., Bagnatti, P., Allegri, R.F. · 2005 · International Psychogeriatrics

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Cerebrovascular disease may cause "vascular depression" (VaD). Calcium channel-blockers are presumed treatments for cerebrovascular disease and might be expected to improve depression and prevent recurrence. OBJECTIVE: To examine the efficacy and tolerability of the use of nimodipine as an augmentation of fluoxetine in the treatment of VaD. DESIGN: A double-blind, randomized clinical trial in which 101 patients with VaD (Alexopoulos criteria) were treated with fluoxetine at standard doses. Patients were randomized to placebo (n=51) or nimodipine (n=50). Treatment outcomes were assessed using the Hamilton Depression Rating Scale (HDRS) regularly up to 8 months after treatment initiation. RESULTS: Depression was reduced in 63% of patients, but those whose treatment was enhanced with nimodipine had greater improvements overall by repeated measures analysis of covariance (ANCOVA) (F(1.80) = 9.76, p=0.001). In addition, a greater proportion of patients treated with fluoxetine-nimodipine (54% vs. 27%) exhibited full remission (chi2(d.f. 1)= 7.3, p = 0.006), with the number needed to treat (NNT) equal to 4 (95% CI 2-12). Of those experiencing full remission in the first 61 days, fewer patients on fluoxetine-nimodipine (3.7%) developed recurrence of major depression as compared to those on fluoxetine alone (35.7%) (chi2(d.f. 1) = 7.56, p = 0.006), NNT 3 (95% CI 2-9). Side-effects were noted in 33.3% of patients in the control group and 48% of the experimental group (chi2(d.f. 1) = 2.25, p = 0.133). CONCLUSIONS: In treating VaD, augmentation of fluoxetine with nimodipine led to better treatment results and lower rates of recurrence. These findings support the argument that augmentation of antidepressant therapy might be helpful in the treatment of cerebrovascular disease, which is involved in the pathogenesis of this type of depression.

Overview

Integrity signals

Registry

Crossref · 10.1017/s1041610205001493

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Research works printed but not linked: 3

  1. Ketter, 2002, Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies, Journal of Clinical Psychiatry, 63, 21
  2. Lopez-Arrieta, J. M. and Birks, J. (2004). Nimodipine for primary degenerative, mixed and vascular dementia (Cochrane Review). In The Cochrane Library, Issue 2. Chichester, U.K.: John Wiley & Sons, Ltd.
  3. Rinkel, 2003, Calcium antagonists for aneurysmal subarachnoid hemorrhage (Cochrane Review), Issue 3

Cited by

See all 90

Metadata

Authors
Taragano, F. E., Bagnatti, P., & Allegri, R. F.
Affiliations
Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (AR)
Venue
International Psychogeriatrics
Publisher
Elsevier BV
Published
2005-09
Volume
17
Issue
3
Pages
487-498
ISSN
1041-6102 (ISSN-L)
OpenAlex
W2218138696
Cited by
90
References
19
Citations by year
2026: 4 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 7 · 2016: 1 · 2015: 1 · 2014: 4 · 2013: 5 · 2012: 6
FWCI
4.03
Type
journal article
Language
en
Open access
Licence
Locations
  • International Psychogeriatrics (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
vascular depression, nimodipine, fluoxetine, antidepressant augmentation, calcium channel blockers, cerebrovascular disease, depression recurrence, remission, adverse effects
MeSH terms
Aged, Argentina, Calcium Channel Blockers, Cerebrovascular Disorders, Depressive Disorder, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Drug Synergism, Drug Therapy, Combination, Female, Fluoxetine, Humans, Male, Middle Aged, Nimodipine, Outcome Assessment, Health Care, Antidepressive Agents, Second-Generation, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression”. https://app.cochat.ai/papers/10.1017/s1041610205001493
The paper
Taragano, F. E., Bagnatti, P., & Allegri, R. F. (2005). A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression”. International Psychogeriatrics. https://doi.org/10.1017/s1041610205001493

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.